Biocon receives Rs536.25cr as subscription money from True North Fund

Consequently, the Board of Biocon Biologics has approved the allotment of 50,25,463 equity shares of Rs10 each at a price of Rs1,067.07 per equity share (including a premium of Rs1,057.07 per equity share) to Activ Pine LLP.

from India Infoline News Service https://ift.tt/2G9Q8iI